Table I.
Clinical and biological characteristics of hemodialysis patients.
| Patients Characteristic | Mean ± SD (N %) |
|---|---|
| Population numbers | N = 100 |
| Biological parameters | |
| Age (years) | 57.50 ± 15.01 |
| Gender (Female /Male) | 36/64 (36% / 64%) |
| Tabacco | 48 (48%) |
| Alcohol | 19 (19%) |
| Duration (months) of dialysis | 79.91 ± 51.13 |
| Weight (m2) | 70.27 ± 12.45 |
| Height (kg) | 1.64 ± 0.10 |
| BMI (kg/m2) | 26.30 ± 4.95 |
| Clinical parameters | |
| CTX (ng/mL) | 1.99 ± 1.40 |
| iPTH (pmol/L) | 32.50 ± 33.42 |
| 25(OH)D (nmol/L) | 37.37 ± 25.45 |
| BALP (ng/mL) | 24.31 ± 19.04 |
| FGF23 (pg/mL) | 212.31 ± 228.90 |
| Calcium (mmol/L) | 2.21 ± 0.20 |
| Phosphate (mmol/L) | 1.96 ± 1.06 |
| Creatinine (mmol/L) | 765.02 ± 606.52 |
| PAL (UI/L) | 100.90 ± 48.33 |
| Bone mineral density data [range] | |
| LS-BMD (g/cm2) | 1.14 ± 0.22 [0.63–1.95] |
| LS-T | -0.58 ± 1.8 [1-4.6–6.1] |
| LS-Z | 0.12 ± 1.74 [-3.8–7.2] |
| FN-BMD (g/cm2) | 0.92 ± 0.16 [0.64–1.4] |
| FN-T | -1.08 ± 1.26 [-3.2–2.4] |
| FN-Z | -0.38 ± 1.15 [-2.2–3.3] |
| TOTAL-BMD (g/cm2) | 1.11 ± 0.12 [0.86–1.41] |
| LS-T LS-T ≥-1 | 58 (58%) |
| -2.5 < LS-T < -1 | 29 (29%) |
| LS-T -2.5 | 13 (13%) |
| LS-T ≥-1 | 58 (58%) |
| FN-T LS-T ≥-1 | 51 (51%) |
| -2.5 < LS-T < -1 | 36 (36%) |
| LS-T -2.5 | 13 (13%) |
BMI: Body Mass index; CTX: Beta cross laps; iPTH: parathyroid hormone; 25(OH)D:25-hydroxyvitamin D; FGF23: fibroblast growth factor 23; PAL: alkaline phosphatase; BALP: bone alkaline phosphatase, BMD: Bone Mineral Density; LS-BMD: Bone Mineral Density in Lumbar spine site; FN-BMD: Bone Mineral Density in Femoral neck; LS-T: T score in Lumbar spine site, FN-T: T score in Femoral neck; LS-Z: Z score in Lumbar spine site, FN-Z: Z score in Femoral neck